Click for best price
Cystic Fibrosis Drugs Market Size, Share 2024
The global Cystic Fibrosis Drugs market was valued at US$ million in 2023 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Cystic Fibrosis Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Cystic Fibrosis Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Cystic Fibrosis Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Drugs. This report contains market size and forecasts of Cystic Fibrosis Drugs in global, including the following market information:
- Global Cystic Fibrosis Drugs Market Revenue, 2019-2024, 2024-2029, ($ millions)
- Global Cystic Fibrosis Drugs Market Sales, 2019-2024, 2024-2029, (K Pcs)
- Global top five Cystic Fibrosis Drugs companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Cystic Fibrosis Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cystic Fibrosis Drugs include Actavis, F. Hoffmann-La Roche, Gilead Sciences, Novartis, Vertex Pharmaceuticals, Abbott, Anthera Pharmaceuticals, Arcturus Therapeutics and Boehringer Ingelheim, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Cystic Fibrosis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cystic Fibrosis Drugs Market, by Type, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Cystic Fibrosis Drugs Market Segment Percentages, by Type, 2023 (%)
- Oral Cystic Fibrosis Drugs
- Injection Cystic Fibrosis Drugs
Global Cystic Fibrosis Drugs Market, by Application, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Cystic Fibrosis Drugs Market Segment Percentages, by Application, 2023 (%)
Global Cystic Fibrosis Drugs Market, By Region and Country, 2019-2024, 2024-2029 ($ Millions) & (K Pcs)
Global Cystic Fibrosis Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cystic Fibrosis Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Cystic Fibrosis Drugs revenues share in global market, 2023 (%)
- Key companies Cystic Fibrosis Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
- Key companies Cystic Fibrosis Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Actavis
- F. Hoffmann-La Roche
- Gilead Sciences
- Novartis
- Vertex Pharmaceuticals
- Abbott
- Anthera Pharmaceuticals
- Arcturus Therapeutics
- Boehringer Ingelheim
- Chiesi Farmaceutici
- Corbus Pharmaceuticals
- Genzyme
- Insmed
- Johnson & Johnson
- Merck Sharp & Dohme
- Neovii Biotech
- Novo Nordisk
- PharmaSwiss
- Pharmaxis
- Proteostasis Therapeutics
- PTC Therapeutics
- United Medical
- Venus Remedies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cystic Fibrosis Drugs, market overview.
Chapter 2: Global Cystic Fibrosis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Cystic Fibrosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cystic Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cystic Fibrosis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cystic Fibrosis Drugs Market, Global Outlook and Forecast 2024-2031 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
124 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cystic Fibrosis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cystic Fibrosis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cystic Fibrosis Drugs Overall Market Size
2.1 Global Cystic Fibrosis Drugs Market Size: 2022 VS 2031
2.2 Global Cystic Fibrosis Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Cystic Fibrosis Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Cystic Fibrosis Drugs Players in Global Market
3.2 Top Global Cystic Fibrosis Drugs Companies Ranked by Revenue
3.3 Global Cystic Fibrosis Drugs Revenue by Companies
3.4 Global Cystic Fibrosis Drugs Sales by Companies
3.5 Global Cystic Fibrosis Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Cystic Fibrosis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cystic Fibrosis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cystic Fibrosis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Cystic Fibrosis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Cystic Fibrosis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cystic Fibrosis Drugs Market Size Markets, 2022 & 2031
4.1.2 Oral Cystic Fibrosis Drugs
4.1.3 Injection Cystic Fibrosis Drugs
4.2 By Type - Global Cystic Fibrosis Drugs Revenue & Forecasts
4.2.1 By Type - Global Cystic Fibrosis Drugs Revenue, 2019-2024
4.2.2 By Type - Global Cystic Fibrosis Drugs Revenue, 2024-2031
4.2.3 By Type - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Cystic Fibrosis Drugs Sales & Forecasts
4.3.1 By Type - Global Cystic Fibrosis Drugs Sales, 2019-2024
4.3.2 By Type - Global Cystic Fibrosis Drugs Sales, 2024-2031
4.3.3 By Type - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Cystic Fibrosis Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cystic Fibrosis Drugs Market Size, 2022 & 2031
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application - Global Cystic Fibrosis Drugs Revenue & Forecasts
5.2.1 By Application - Global Cystic Fibrosis Drugs Revenue, 2019-2024
5.2.2 By Application - Global Cystic Fibrosis Drugs Revenue, 2024-2031
5.2.3 By Application - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
5.3 By Application - Global Cystic Fibrosis Drugs Sales & Forecasts
5.3.1 By Application - Global Cystic Fibrosis Drugs Sales, 2019-2024
5.3.2 By Application - Global Cystic Fibrosis Drugs Sales, 2024-2031
5.3.3 By Application - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
5.4 By Application - Global Cystic Fibrosis Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Cystic Fibrosis Drugs Market Size, 2022 & 2031
6.2 By Region - Global Cystic Fibrosis Drugs Revenue & Forecasts
6.2.1 By Region - Global Cystic Fibrosis Drugs Revenue, 2019-2024
6.2.2 By Region - Global Cystic Fibrosis Drugs Revenue, 2024-2031
6.2.3 By Region - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Cystic Fibrosis Drugs Sales & Forecasts
6.3.1 By Region - Global Cystic Fibrosis Drugs Sales, 2019-2024
6.3.2 By Region - Global Cystic Fibrosis Drugs Sales, 2024-2031
6.3.3 By Region - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Cystic Fibrosis Drugs Revenue, 2019-2031
6.4.2 By Country - North America Cystic Fibrosis Drugs Sales, 2019-2031
6.4.3 US Cystic Fibrosis Drugs Market Size, 2019-2031
6.4.4 Canada Cystic Fibrosis Drugs Market Size, 2019-2031
6.4.5 Mexico Cystic Fibrosis Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Cystic Fibrosis Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Cystic Fibrosis Drugs Sales, 2019-2031
6.5.3 Germany Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.4 France Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.5 U.K. Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.6 Italy Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.7 Russia Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Cystic Fibrosis Drugs Market Size, 2019-2031
6.5.9 Benelux Cystic Fibrosis Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Cystic Fibrosis Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Cystic Fibrosis Drugs Sales, 2019-2031
6.6.3 China Cystic Fibrosis Drugs Market Size, 2019-2031
6.6.4 Japan Cystic Fibrosis Drugs Market Size, 2019-2031
6.6.5 South Korea Cystic Fibrosis Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Cystic Fibrosis Drugs Market Size, 2019-2031
6.6.7 India Cystic Fibrosis Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Cystic Fibrosis Drugs Revenue, 2019-2031
6.7.2 By Country - South America Cystic Fibrosis Drugs Sales, 2019-2031
6.7.3 Brazil Cystic Fibrosis Drugs Market Size, 2019-2031
6.7.4 Argentina Cystic Fibrosis Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cystic Fibrosis Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Cystic Fibrosis Drugs Sales, 2019-2031
6.8.3 Turkey Cystic Fibrosis Drugs Market Size, 2019-2031
6.8.4 Israel Cystic Fibrosis Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Cystic Fibrosis Drugs Market Size, 2019-2031
6.8.6 UAE Cystic Fibrosis Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Actavis
7.1.1 Actavis Company Summary
7.1.2 Actavis Business Overview
7.1.3 Actavis Cystic Fibrosis Drugs Major Product Offerings
7.1.4 Actavis Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Actavis Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Major Product Offerings
7.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Company Summary
7.3.2 Gilead Sciences Business Overview
7.3.3 Gilead Sciences Cystic Fibrosis Drugs Major Product Offerings
7.3.4 Gilead Sciences Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.3.5 Gilead Sciences Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Cystic Fibrosis Drugs Major Product Offerings
7.4.4 Novartis Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Vertex Pharmaceuticals
7.5.1 Vertex Pharmaceuticals Company Summary
7.5.2 Vertex Pharmaceuticals Business Overview
7.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Major Product Offerings
7.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.5.5 Vertex Pharmaceuticals Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Cystic Fibrosis Drugs Major Product Offerings
7.6.4 Abbott Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Abbott Key News & Latest Developments
7.7 Anthera Pharmaceuticals
7.7.1 Anthera Pharmaceuticals Company Summary
7.7.2 Anthera Pharmaceuticals Business Overview
7.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Major Product Offerings
7.7.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Anthera Pharmaceuticals Key News & Latest Developments
7.8 Arcturus Therapeutics
7.8.1 Arcturus Therapeutics Company Summary
7.8.2 Arcturus Therapeutics Business Overview
7.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Major Product Offerings
7.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Arcturus Therapeutics Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Major Product Offerings
7.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 Chiesi Farmaceutici
7.10.1 Chiesi Farmaceutici Company Summary
7.10.2 Chiesi Farmaceutici Business Overview
7.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Major Product Offerings
7.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Chiesi Farmaceutici Key News & Latest Developments
7.11 Corbus Pharmaceuticals
7.11.1 Corbus Pharmaceuticals Company Summary
7.11.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Business Overview
7.11.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Major Product Offerings
7.11.4 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.11.5 Corbus Pharmaceuticals Key News & Latest Developments
7.12 Genzyme
7.12.1 Genzyme Company Summary
7.12.2 Genzyme Cystic Fibrosis Drugs Business Overview
7.12.3 Genzyme Cystic Fibrosis Drugs Major Product Offerings
7.12.4 Genzyme Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.12.5 Genzyme Key News & Latest Developments
7.13 Insmed
7.13.1 Insmed Company Summary
7.13.2 Insmed Cystic Fibrosis Drugs Business Overview
7.13.3 Insmed Cystic Fibrosis Drugs Major Product Offerings
7.13.4 Insmed Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.13.5 Insmed Key News & Latest Developments
7.14 Johnson & Johnson
7.14.1 Johnson & Johnson Company Summary
7.14.2 Johnson & Johnson Business Overview
7.14.3 Johnson & Johnson Cystic Fibrosis Drugs Major Product Offerings
7.14.4 Johnson & Johnson Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.14.5 Johnson & Johnson Key News & Latest Developments
7.15 Merck Sharp & Dohme
7.15.1 Merck Sharp & Dohme Company Summary
7.15.2 Merck Sharp & Dohme Business Overview
7.15.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Major Product Offerings
7.15.4 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.15.5 Merck Sharp & Dohme Key News & Latest Developments
7.16 Neovii Biotech
7.16.1 Neovii Biotech Company Summary
7.16.2 Neovii Biotech Business Overview
7.16.3 Neovii Biotech Cystic Fibrosis Drugs Major Product Offerings
7.16.4 Neovii Biotech Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.16.5 Neovii Biotech Key News & Latest Developments
7.17 Novo Nordisk
7.17.1 Novo Nordisk Company Summary
7.17.2 Novo Nordisk Business Overview
7.17.3 Novo Nordisk Cystic Fibrosis Drugs Major Product Offerings
7.17.4 Novo Nordisk Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.17.5 Novo Nordisk Key News & Latest Developments
7.18 PharmaSwiss
7.18.1 PharmaSwiss Company Summary
7.18.2 PharmaSwiss Business Overview
7.18.3 PharmaSwiss Cystic Fibrosis Drugs Major Product Offerings
7.18.4 PharmaSwiss Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.18.5 PharmaSwiss Key News & Latest Developments
7.19 Pharmaxis
7.19.1 Pharmaxis Company Summary
7.19.2 Pharmaxis Business Overview
7.19.3 Pharmaxis Cystic Fibrosis Drugs Major Product Offerings
7.19.4 Pharmaxis Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.19.5 Pharmaxis Key News & Latest Developments
7.20 Proteostasis Therapeutics
7.20.1 Proteostasis Therapeutics Company Summary
7.20.2 Proteostasis Therapeutics Business Overview
7.20.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Major Product Offerings
7.20.4 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.20.5 Proteostasis Therapeutics Key News & Latest Developments
7.21 PTC Therapeutics
7.21.1 PTC Therapeutics Company Summary
7.21.2 PTC Therapeutics Business Overview
7.21.3 PTC Therapeutics Cystic Fibrosis Drugs Major Product Offerings
7.21.4 PTC Therapeutics Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.21.5 PTC Therapeutics Key News & Latest Developments
7.22 United Medical
7.22.1 United Medical Company Summary
7.22.2 United Medical Business Overview
7.22.3 United Medical Cystic Fibrosis Drugs Major Product Offerings
7.22.4 United Medical Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.22.5 United Medical Key News & Latest Developments
7.23 Venus Remedies
7.23.1 Venus Remedies Company Summary
7.23.2 Venus Remedies Business Overview
7.23.3 Venus Remedies Cystic Fibrosis Drugs Major Product Offerings
7.23.4 Venus Remedies Cystic Fibrosis Drugs Sales and Revenue in Global (2019-2024)
7.23.5 Venus Remedies Key News & Latest Developments
8 Global Cystic Fibrosis Drugs Production Capacity, Analysis
8.1 Global Cystic Fibrosis Drugs Production Capacity, 2019-2031
8.2 Cystic Fibrosis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Cystic Fibrosis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cystic Fibrosis Drugs Supply Chain Analysis
10.1 Cystic Fibrosis Drugs Industry Value Chain
10.2 Cystic Fibrosis Drugs Upstream Market
10.3 Cystic Fibrosis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cystic Fibrosis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Cystic Fibrosis Drugs in Global Market
Table 2. Top Cystic Fibrosis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cystic Fibrosis Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Cystic Fibrosis Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Cystic Fibrosis Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Cystic Fibrosis Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Cystic Fibrosis Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Cystic Fibrosis Drugs Product Type
Table 9. List of Global Tier 1 Cystic Fibrosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cystic Fibrosis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Cystic Fibrosis Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Cystic Fibrosis Drugs Sales (K Pcs), 2024-2031
Table 16. By Application ? Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By Application - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2024-2031
Table 19. By Application - Global Cystic Fibrosis Drugs Sales (K Pcs), 2019-2024
Table 20. By Application - Global Cystic Fibrosis Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Cystic Fibrosis Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Cystic Fibrosis Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Cystic Fibrosis Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Cystic Fibrosis Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Cystic Fibrosis Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Cystic Fibrosis Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Cystic Fibrosis Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Cystic Fibrosis Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Cystic Fibrosis Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Cystic Fibrosis Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Cystic Fibrosis Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Cystic Fibrosis Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Cystic Fibrosis Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Cystic Fibrosis Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Cystic Fibrosis Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Cystic Fibrosis Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Cystic Fibrosis Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Cystic Fibrosis Drugs Sales, (K Pcs), 2024-2031
Table 46. Actavis Company Summary
Table 47. Actavis Cystic Fibrosis Drugs Product Offerings
Table 48. Actavis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Actavis Key News & Latest Developments
Table 50. F. Hoffmann-La Roche Company Summary
Table 51. F. Hoffmann-La Roche Cystic Fibrosis Drugs Product Offerings
Table 52. F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. F. Hoffmann-La Roche Key News & Latest Developments
Table 54. Gilead Sciences Company Summary
Table 55. Gilead Sciences Cystic Fibrosis Drugs Product Offerings
Table 56. Gilead Sciences Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. Gilead Sciences Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Cystic Fibrosis Drugs Product Offerings
Table 60. Novartis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Vertex Pharmaceuticals Company Summary
Table 63. Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Offerings
Table 64. Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. Vertex Pharmaceuticals Key News & Latest Developments
Table 66. Abbott Company Summary
Table 67. Abbott Cystic Fibrosis Drugs Product Offerings
Table 68. Abbott Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Abbott Key News & Latest Developments
Table 70. Anthera Pharmaceuticals Company Summary
Table 71. Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Offerings
Table 72. Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. Anthera Pharmaceuticals Key News & Latest Developments
Table 74. Arcturus Therapeutics Company Summary
Table 75. Arcturus Therapeutics Cystic Fibrosis Drugs Product Offerings
Table 76. Arcturus Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Arcturus Therapeutics Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Cystic Fibrosis Drugs Product Offerings
Table 80. Boehringer Ingelheim Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. Chiesi Farmaceutici Company Summary
Table 83. Chiesi Farmaceutici Cystic Fibrosis Drugs Product Offerings
Table 84. Chiesi Farmaceutici Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Chiesi Farmaceutici Key News & Latest Developments
Table 86. Corbus Pharmaceuticals Company Summary
Table 87. Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Offerings
Table 88. Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 89. Corbus Pharmaceuticals Key News & Latest Developments
Table 90. Genzyme Company Summary
Table 91. Genzyme Cystic Fibrosis Drugs Product Offerings
Table 92. Genzyme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 93. Genzyme Key News & Latest Developments
Table 94. Insmed Company Summary
Table 95. Insmed Cystic Fibrosis Drugs Product Offerings
Table 96. Insmed Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 97. Insmed Key News & Latest Developments
Table 98. Johnson & Johnson Company Summary
Table 99. Johnson & Johnson Cystic Fibrosis Drugs Product Offerings
Table 100. Johnson & Johnson Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 101. Johnson & Johnson Key News & Latest Developments
Table 102. Merck Sharp & Dohme Company Summary
Table 103. Merck Sharp & Dohme Cystic Fibrosis Drugs Product Offerings
Table 104. Merck Sharp & Dohme Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 105. Merck Sharp & Dohme Key News & Latest Developments
Table 106. Neovii Biotech Company Summary
Table 107. Neovii Biotech Cystic Fibrosis Drugs Product Offerings
Table 108. Neovii Biotech Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 109. Neovii Biotech Key News & Latest Developments
Table 110. Novo Nordisk Company Summary
Table 111. Novo Nordisk Cystic Fibrosis Drugs Product Offerings
Table 112. Novo Nordisk Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 113. Novo Nordisk Key News & Latest Developments
Table 114. PharmaSwiss Company Summary
Table 115. PharmaSwiss Cystic Fibrosis Drugs Product Offerings
Table 116. PharmaSwiss Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 117. PharmaSwiss Key News & Latest Developments
Table 118. Pharmaxis Company Summary
Table 119. Pharmaxis Cystic Fibrosis Drugs Product Offerings
Table 120. Pharmaxis Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 121. Pharmaxis Key News & Latest Developments
Table 122. Proteostasis Therapeutics Company Summary
Table 123. Proteostasis Therapeutics Cystic Fibrosis Drugs Product Offerings
Table 124. Proteostasis Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 125. Proteostasis Therapeutics Key News & Latest Developments
Table 126. PTC Therapeutics Company Summary
Table 127. PTC Therapeutics Cystic Fibrosis Drugs Product Offerings
Table 128. PTC Therapeutics Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 129. PTC Therapeutics Key News & Latest Developments
Table 130. United Medical Company Summary
Table 131. United Medical Cystic Fibrosis Drugs Product Offerings
Table 132. United Medical Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 133. United Medical Key News & Latest Developments
Table 134. Venus Remedies Company Summary
Table 135. Venus Remedies Cystic Fibrosis Drugs Product Offerings
Table 136. Venus Remedies Cystic Fibrosis Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 137. Venus Remedies Key News & Latest Developments
Table 138. Cystic Fibrosis Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 139. Global Cystic Fibrosis Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 140. Global Cystic Fibrosis Drugs Production by Region, 2019-2024 (K Pcs)
Table 141. Global Cystic Fibrosis Drugs Production by Region, 2024-2031 (K Pcs)
Table 142. Cystic Fibrosis Drugs Market Opportunities & Trends in Global Market
Table 143. Cystic Fibrosis Drugs Market Drivers in Global Market
Table 144. Cystic Fibrosis Drugs Market Restraints in Global Market
Table 145. Cystic Fibrosis Drugs Raw Materials
Table 146. Cystic Fibrosis Drugs Raw Materials Suppliers in Global Market
Table 147. Typical Cystic Fibrosis Drugs Downstream
Table 148. Cystic Fibrosis Drugs Downstream Clients in Global Market
Table 149. Cystic Fibrosis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cystic Fibrosis Drugs Segment by Type in 2022
Figure 2. Cystic Fibrosis Drugs Segment by Application in 2022
Figure 3. Global Cystic Fibrosis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cystic Fibrosis Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Cystic Fibrosis Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Cystic Fibrosis Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Cystic Fibrosis Drugs Revenue in 2022
Figure 9. By Type - Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Cystic Fibrosis Drugs Price (USD/Pcs), 2019-2031
Figure 13. By Application - Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Application - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 15. By Application - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 16. By Application - Global Cystic Fibrosis Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Cystic Fibrosis Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Cystic Fibrosis Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 23. US Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 28. Germany Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 37. China Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Cystic Fibrosis Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Cystic Fibrosis Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Cystic Fibrosis Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Cystic Fibrosis Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Cystic Fibrosis Drugs by Region, 2022 VS 2031
Figure 54. Cystic Fibrosis Drugs Industry Value Chain
Figure 55. Marketing Channels
